Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year […]
